Individual C. elegans body wall muscles express two pharmacologically distinct nicotinic receptors: a levamisole-sensitive and a levamisole-insensitive receptor class. We have identified ACR-16 as an essential subunit (Touroutine et.al. JBC) of the levamisole-insensitive receptor. This receptor contributes to synaptic transmission at the C. elegans neuromuscular junction (NMJ) and also functions in neurons to mediate nicotine-dependent behavior (Feng et al., Cell). Several components required to traffic or localize the levamisole-sensitive receptor have been identified. However, molecules required to target the ACR-16 receptor to post-synaptic sites remain to be identified, in part due to the lack of a screenable phenotype in
acr-16 mutants. We developed two strategies to identify those molecules. 1. We conducted a genetic screen to identify mutants with altered ACR-16::GFP expression. 2. We generated a strain expressing an ACR-16 gain-of-function receptor which desensitizes slowly and causes lethality when expressed in worm muscles. However, worms grown on plates with RNAi against
acr-16 survive and are healthy. This allows as to mutagenise
acr-16 RNAi-treated worms and screen for suppressors of the lethal phenotype on OP50 plates. Utilizing the first strategy and after screening 2400 haploid genomes, we identified several candidates in which ACR-16::GFP expression is altered. Among these, we found a new allele of
ric-3, a gene that is required for both levamisome-receptor and ACR-16 receptor function (Halevi et. al). Another mutant identified in this screen exhibits a dramatic reduction (only 5% of the signal remains) in the ACR-16::GFP puncta that localize adjacent to UNC-17-positive puncta in the ventral nerve cord. Double mutants of
unc-63 and this mutant exhibit decreased thrashing rates (77% less) when compared to
unc-63 mutants alone, suggesting they have reduced functional ACR-16 receptors at the NMJ. Mutants isolated from both screens will be mapped and characterized. Touroutine et. al JBC 2005 Jul 22;280(29):27013-21. Feng Z et. al. Cell 127:621-633. Halevi et.al EMBO J, 2002 Mar 1;21(5):1012-20.